Conducting radiogenomic research - Do not forget careful consideration of the clinical data

Christian Nicolaj Andreassen*, Gillian C. Barnett, Johannes A. Langendijk, Jan Alsner, Dirk De Ruysscher, Mechtild Krause, Soren M. Bentzen, Joanne S. Haviland, Clare Griffin, Philip Poortmans, John R. Yarnold

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities.
Original languageEnglish
Pages (from-to)337-340
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - Dec 2012


  • Normal tissue radiosensitivity
  • Predictive markers
  • Single nucleotide polymorphisms

Cite this